FREMONT, Calif.--(BUSINESS WIRE)--ARYx Therapeutics, Inc. (NASDAQ:ARYX) today announced the appointment of David Beier to its board of directors. Mr. Beier is a veteran of the biotechnology industry and has been instrumental in the development of United States public policy impacting biotechnology companies, having served in both the industry and the Clinton Administration.
